🗂️第30章：Drugs
| HS Code | Product Name | Import Duty (MFN) | Export Rebate | VAT |
|---|---|---|---|---|
| 3001200010 | Extracts of glands or other organs or of their secretions of endangered wild animals | 3% | 0 | - |
| 3001200020 | Human glands, organs and their secretion extracts | 3% | 15.00 | 17.00 |
| 3001200021 | Human extracts of glands or organs or of their secretions,containing human genetic resources | 3% | 13 | - |
| 3001200029 | Other human extracts of glands or organs or of their secretions | 3% | 13 | - |
| 3001200090 | Other extracts of glands or other organs or of their secretions | 3% | 13 | - |
| 3001901000 | Heparin and its salts | 3% | 13 | - |
| 3001909010 | Snake venom products | 3% | 15.00 | 17.00 |
| 3001909011 | Endangered snake venom products (for treatment or prevention of diseases) | 3% | 0 | 13 |
| 3001909019 | Non endangered snake venom products (for treatment or prevention of diseases) | 3% | 13 | 13 |
| 3001909020 | Other human or animal substances,containing human genetic resources | 3% | 10 | - |
| 3001909091 | Other substances of endangered animal, prepared for therapeutic or prophylactic uses | 3% | 0 | - |
| 3001909092 | Human glands, organs, tissues (for the treatment or prevention of diseases) | 3% | 10/13 | - |
| 3001909099 | Other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 3% | 10/13 | - |
| 3002110000 | A test box for malaria | 3% | 17.00 | 17.00 |
| 3002120011 | Salicylic acid-promoting erythrocytes, erythrocyte derivatives, ammonium methacrylate-promoting erythrocytes, di-promoting erythrocytes, and erythrocyte-promoting erythrocytes (EPO) | 3% | 0.00 | 17.00 |
| 3002120012 | Insulin-like growth factor 1 (IGF-1) and its analogues | 3% | 0.00 | 17.00 |
| 3002120013 | Mechanical growth factor class | 3% | 0.00 | 17.00 |
| 3002120014 | Adult fibroblast growth factors (FGFs) | 3% | 0.00 | 17.00 |
| 3002120015 | Hepatocellular growth factor (HGF) | 3% | 0.00 | 17.00 |
| 3002120016 | Platelet-derived growth factor (PDGF) | 3% | 0.00 | 17.00 |
| 3002120017 | Vascular endothelial growth factor (VEGF) | 3% | 0.00 | 17.00 |
| 3002120018 | Transforming growth factor-β (TGF-β) inhibitor class | 3% | 0.00 | 17.00 |
| 3002120019 | Penny Sands and Rothschild | 3% | 0.00 | 17.00 |
| 3002120021 | Activators of hypoxia inducing factors (HIF) and stabilizers of hypoxia inducing factors (HIF) | 3% | 0.00 | 17.00 |
| 3002120022 | EPO-Fc ((IgG4) fusion protein, also known as EPO-Fc fusion protein | 3% | 0.00 | 17.00 |
| 3002120023 | Antiserum and other blood,containing human genetic resources | 3% | 13 | - |
| 3002120030 | Veterinary serum products | 3% | 13 | - |
| 3002120090 | Other antiserum and other blood components | 3% | 0.00 | 17.00 |
| 3002120093 | Drug preparations for rare diseases (including the first batch, the second batch and the third batch of commodities in the list of drugs for rare diseases that meet the provisions of the value-added tax policy) | 3% | 13 | - |
| 3002120094 | Other antiserum and blood containing endangered animal components | 3% | 0 | 13 |
| 3002120099 | Antisera, other blood fractions and immunological products | 3% | 13 | - |
| 3002130000 | Unmixed immunological products, doses not prescribed or manufactured for retail packaging | 3% | 17.00 | 17.00 |
| 3002130010 | Protein assimilation preparations and peptide hormone immunomodulatory products, unmixed, listed in the Doping Catalogue,not put up in measured doses or in forms or packings for retail sale | 3% | 0 | 13 |
| 3002130090 | Other Immunogical products, unmixed,not put up in measured doses or in forms or packings for retail sale | 3% | 0 | 13 |
| 3002140000 | Immunological products,mixed,not put up in measured doses or in forms or packings for retail sale | 3% | 13 | - |
| 3002150000 | Immunological products, prescribed doses or manufactured in retail packaging | 3% | 17.00 | 17.00 |
| 3002150010 | Anti cancer (anti cancer) drug preparations (excluding cancer adjuvant therapy drugs) (including the first, second and third batches of anti-cancer drugs in line with the VAT policy) | 3% | 13 | - |
| 3002150030 | Drug preparations for rare diseases (including the first batch, the second batch and the third batch of commodities in the list of drugs for rare diseases that meet the provisions of the value-added tax policy) | 3% | 13 | - |
| 3002150040 | Veterinary immunological in vivo diagnostic products (prepared dose) | 3% | 0 | 13 |
| 3002150050 | Protein assimilation preparations and peptide hormone immunomodulatory products, listed in the Doping Catalogue , not put up in measured doses or in forms or packings for retail sale | 3% | 0 | 13 |
| 3002150090 | Other immunological products,put up in measured doses or in forms or packings for retail sale | 3% | 13 | - |
| 3002190000 | Other antiserums, other blood components and immunological products, whether or not modified or produced by biological processes | 3% | 17.00 | 17.00 |
| 3002200000 | Vaccines for humans | 3% | 17.00 | 17.00 |
| 3002300000 | Vaccines for animals | 3% | 17.00 | 17.00 |
| 3002410011 | New Coronavirus (COVID-19) vaccine has been dosed or made into retail packaging | 3% | 0 | 13 |
| 3002410019 | New Coronavirus (COVID-19) vaccine is not prepared for dosage or made into retail packaging | 3% | 0 | 13 |
| 3002410090 | vaccines for others | 3% | 0 | 13 |
| 3002420000 | Veterinary or Veterinary medicine | 3% | 0 | 13 |
| 3002492000 | Ricitoxin | 3% | 0 | 13 |
| 3002493010 | Dual purpose items control bacteria and viruses | 3% | 0 | 13 |
| 3002493020 | Bacillus thuringiensis, Bacillus subtilis | 3% | 0 | 13 |
| 3002493090 | Other bacteria and viruses | 3% | 0 | 13 |
| 3002499010 | Mycelium sclerotiorum, Paecilomyces lilacinus, Trichoderma harziana, SPP | 3% | 0 | 13 |
| 3002499020 | Other toxins, cultures of microorganisms (excluding yeasts) of dual-use items contorlled and similar products | 3% | 0 | 13 |
| 3002499090 | Other toxins, cultured microorganisms (excluding yeast) and similar products | 3% | 0 | 13 |
| 3002510010 | Cell therapy products in the list of anti-cancer drugs | 3% | 0 | 3 |
| 3002510090 | Other cell therapy products | 3% | 0 | 13 |
| 3002590000 | Other cell cultures, whether or not modified | 3% | 0 | 13 |
| 3002901000 | Toxins in stone | 3% | 15.00 | 17.00 |
| 3002902000 | Toxins from measles | 3% | 15.00 | 17.00 |
| 3002903010 | Two-use control of bacteria and viruses | 3% | 17.00 | 17.00 |
| 3002903020 | Su-Yung's goldfinch | 3% | 17.00 | 17.00 |
| 3002903030 | Dry Weed Blastoma | 3% | 17.00 | 17.00 |
| 3002903090 | Other bacteria and viruses | 3% | 17.00 | 17.00 |
| 3002904010 | Genetics materials and gene-modified organisms under control of sensitive items | 3% | 13 | - |
| 3002904090 | Other genetics materials and gene-modified organisms | 3% | 13 | - |
| 3002909001 | Human blood | 3% | 13 | 13 |
| 3002909010 | Blood products from endangered animals for therapeutic, preventive or diagnostic purposes | 3% | 0 | 13 |
| 3002909011 | Endangered animal blood products | 3% | 0.00 | 17.00 |
| 3002909019 | Other blood products, animal blood products | 3% | 17.00 | 17.00 |
| 3002909021 | Mycobacterium nuclei | 3% | 17.00 | 17.00 |
| 3002909022 | Yellow-bellied frog | 3% | 17.00 | 17.00 |
| 3002909023 | The Hatsumi Mycelium | 3% | 17.00 | 17.00 |
| 3002909024 | Widows and widowers | 3% | 17.00 | 17.00 |
| 3002909090 | Other animal blood products used for treatment, prevention or diagnosis | 3% | 13 | 13 |
| 3002909091 | Two-use controlled toxins | 3% | 17.00 | 17.00 |
| 3002909099 | Human blood, other toxins, etc. | 3% | 17.00 | 17.00 |
| 3003101100 | Ampicillin (not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003101200 | Amoxycillin (not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003101300 | Penicillin v (not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003101900 | Other medicaments containing penicillins(not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003109000 | Other medicaments consisting of penicillins or streptomycins(consisting of two or more constituents which have been mixed together, not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003201100 | Cefotaxime(not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003201200 | Ceftazidime(not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003201300 | Cefoxitin(not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003201400 | Ceftezole(not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003201500 | Cefaclor(not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003201600 | Cefuroxime(not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003201700 | Ceftriaxone(not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003201800 | Cefoperazone(not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003201900 | Other medicaments containing cephamycins(consisting of two or more constituents which have been mixed together, not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003209000 | Medicaments consisting of other antibiotics(consisting of two or more constituents which have been mixed together, not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003310000 | Medicaments containing insulin(consisting of two or more constituents which have been mixed together, but not containing antibiotics, not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003390000 | Other medicaments containing hormones or other prouducts of heading 29.37(consisting of two or more constituents which have been mixed together, but not containing antibiotics, not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003410000 | Drug mixtures containing ephedrine and its salts (in unprescribed doses or in non-retail packaging, mixtures containing two or more ingredients) | 5% | 13 | - |
| 3003420000 | Drug mixtures containing pseudoephedrine (INN) and its salts (unprescribed dose or in non-retail packaging, mixtures containing two or more ingredients) | 5% | 13 | - |
| 3003430000 | Drug mixtures containing norephedrine and its salts (in unprescribed doses or in non-retail packaging, mixtures containing two or more ingredients) | 5% | 13 | - |
| 3003490010 | Medicaments containing quinine or its salts(consisting of two or more constituents which have been mixed together, not put up in measured doses or in forms or packings for retail sale) | 5% | 13 | - |
| 3003490090 | Other medicaments containing alkaloids or derivatives thereof(consisting of two or more constituents which have been mixed together, but not containing hormones or other prouducts of heading 29.37 or antibiotics, not put up in measured doses or in forms o | 5% | 13 | - |
| 3003601000 | Drug mixtures containing artemisinin and its derivatives (in unprescribed doses or in non-retail packaging, mixtures containing two or more ingredients) | 0% | 13 | - |
| 3003609010 | Medicaments containing sulfa drugs(consisting of two or more constituents which have been mixed together, not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003609020 | Medicaments containing endangered animals and plants(consisting of two or more constituents which have been mixed together, not put up in measured doses or in forms or packings for retail sale) | 0% | 0 | - |
| 3003609090 | Other, containing antimalarial active principles described in subheading note 2 to this chapter(consisting of two or more constituents which have been mixed together, but not containing hormones or other prouducts of heading 29.37 or antibiotics, not put | 0% | 13 | - |
| 3003900010 | Other medicaments containing sulfa drugs(consisting of two or more constituents which have been mixed together, not put up in measured doses or in forms or packings for retail sale) | 0% | 0 | - |
| 3003900020 | Other medicaments containing endangered animals and plants(consisting of two or more constituents which have been mixed together, not put up in measured doses or in forms or packings for retail sale) | 0% | 0 | - |
| 3003900030 | Other medicaments containing sulfa drugs(consisting of two or more constituents which have been mixed together, not put up in measured doses or in forms or packings for retail sale) | 0% | 13 | - |
| 3003900040 | Mixed drugs containing Sibutramine (without fixed dose or retail packaging) | 0% | 0 | 0 |
| 3003900090 | Other medicaments, containing other two or more constituents, not elsewhere specified or included, not put up in measured doses or in forms of packings for retail sale | 0% | 13 | - |
| 3004101100 | Ampicillin, put up in measured doses or in forms of packings for retail sale | 0% | 13 | - |
| 3004101110 | Animal use of procaine for penicillin and nephrotoxins | 6% | 15.00 | 17.00 |
| 3004101190 | The preparation of ammonium penicillin | 0% | 15.00 | 17.00 |
| 3004101200 | The preparation of penicillin | 0% | 15.00 | 17.00 |
| 3004101210 | Formulated dosage of veterinary preparations (including commodities in the Management Catalogue of imported veterinary drugs; including retail packaging) | 0% | 13 | - |
| 3004101290 | Other ampicillin preparations (including retail packaging) | 0% | 13 | - |
| 3004101300 | Penicillin v, put up in measured doses or in forms of packings for retail sale | 0% | 13 | - |
| 3004101900 | Other dosed preparations of penicillin | 6% | 15.00 | 17.00 |
| 3004101910 | Formulated dosage of veterinary preparations (including commodities in the Management Catalogue of imported veterinary drugs; including retail packaging) | 0% | 13 | - |
| 3004101990 | Other prescribed doses of penicillin preparations (including retail packaging) | 0% | 13 | - |
| 3004109000 | Other medicaments consisting of penicillins or streptomycins, including retail packaging | 0% | 13 | - |
| 3004201100 | Cefotaxime, put up in measured doses or in forms or packings for retail sale | 0% | 13 | - |
| 3004201200 | Ceftazidime, put up in measured doses or in forms or packings for retail sale | 0% | 13 | - |
| 3004201300 | Cefoxitin, put up in measured doses or in forms or packings for retail sale | 0% | 13 | - |
| 3004201400 | Ceftezole, put up in measured doses or in forms or packings for retail sale | 0% | 13 | - |
| 3004201500 | Cefaclor, put up in measured doses or in forms or packings for retail sale | 0% | 13 | - |
| 3004201600 | Cefuroxime, put up in measured doses or in forms or packings for retail sale | 0% | 13 | - |
| 3004201700 | Ceftriaxone, put up in measured doses or in forms or packings for retail sale | 0% | 13 | - |
| 3004201800 | Cefoperazone, put up in measured doses or in forms or packings for retail sale | 0% | 13 | - |
| 3004201911 | For veterinary use with doses prescribed, titrating preparations | 6% | 15.00 | 17.00 |
| 3004201912 | Titanium crystals, sulphate titanium preparations for veterinary use with dosage adjustment | 6% | 15.00 | 17.00 |
| 3004201920 | Formulated dosage of veterinary preparations (including commodities in the Management Catalogue of imported veterinary drugs; including retail packaging) | 0% | 13 | - |
| 3004201990 | Other cephalosporin preparations, put up in measured doses or in forms of packings for retail sale | 0% | 13 | - |
| 3004209011 | For veterinary use, prescribed doses of tyrosine, tetrahydrocortisone and tyrosine | 6% | 15.00 | 17.00 |
| 3004209012 | For veterinary use, prescribed doses of phenylalanine, doramycin, sulfuric acid and phenylalanine | 6% | 15.00 | 17.00 |
| 3004209013 | Preparation of sulphuric acid biphenyl chains for veterinary use | 6% | 15.00 | 17.00 |
| 3004209020 | Formulated dosage of veterinary preparations (including commodities in the Management Catalogue of imported veterinary drugs; including retail packaging) | 0% | 13 | - |
| 3004209090 | Medicines that contain other antimicrobials at prescribed doses | 6% | 15.00 | 17.00 |
| 3004209091 | Anti cancer (anti cancer) drug preparations (excluding cancer adjuvant therapy drugs) (including the first batch and the third batch of related commodities in the list of anti-cancer drugs) | 0% | 13 | - |
| 3004209099 | Medicaments of other antibiotics, put up in measu- red doses or in forms of packings for retail sale | 0% | 13 | - |
| 3004311010 | Single preparations, containing recombinant human insulin, put up in measured doses or packings for retail sale | 0% | 13 | - |
| 3004311090 | Other medicaments, containing recombinant human insulin, without antibiotics, put up in measured doses or packings for retail sale | 0% | 13 | - |
| 3004319010 | Other single preparations, containing insulin, put up in measured doses or packings for retail sale | 0% | 13 | - |
| 3004319090 | Other medicaments, containing insulin, without antibiotics, put up in measured doses or packings for retail sale | 0% | 13 | - |
| 3004320011 | Single preparation containing andostenediol or androstenedione, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320012 | Single preparation containing formebolone, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320013 | Single preparation containing androst-4-ene-3β, 17α-diol, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320014 | Single preparation containing androst-5-ene-3β,17α-diol, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320015 | Single preparation with 4-androstenediol and ethylestrenol, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320016 | Single preparation containing 5-androstenedione isomer, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320017 | Single preparation containing 5α-androstane-3α and 17β-diol or 5β-androstane-3α and 17β-diol isomer,including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320018 | Single preparation containing 5α-androstane-3β and 17α-diol isomer, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320019 | Single preparation containing bolasterone, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320021 | Single preparation containing boldenone, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320022 | Single preparation containing boldione, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320023 | Single preparation containing calusterone or danazol, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320024 | Single preparation containing clostebol, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320025 | Single preparation containing dehydrochlorme- thyltestosterone, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320026 | Single dose preparations (including derivatives and structural analogues, including retail packaging) with methylchlorostilbestrol | 0% | 13 | - |
| 3004320028 | Single preparation containing prasterone or dromostanolone, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320029 | Single preparation containing deoxymethyltestosterone or dihydrotestosterone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320031 | Single preparation containing epi-dihydrotestosterone or fluoxymesterone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320032 | Single preparation containing furazabol, and their derivatives and structural analogues, in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320033 | Single preparation containing gestrinone or 4-hydroxyltestosterone, and their derivatives and struct- ural analogues, put up in measured doses, pack- ings for retail sale | 0% | 13 | - |
| 3004320034 | Single preparation containing 3α-hydroxide5α- androstane-17-ketone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320035 | Single preparation containing mestanolone or methandienone, and their derivatives and struct- ural analogues, put up in measured doses, packi- ngs for retail sale | 0% | 13 | - |
| 3004320036 | Single preparation containing 2α, 17α-dimethyl-5α- androstane-3-ketone -17β-alcohol, and their derivatives, structural analogues, in measured doses, packings for retail sale | 0% | 0 | 13 |
| 3004320037 | Single preparation containing 17α- meth-yl-17β- hydroxide-4, 9(10)-diolefin-3-ketone, including their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320038 | Single preparation containing methyl-1-testosteroneor methylnortestosterone, and their derivatives and structural analogues, in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320039 | Single preparation containing 7α-methyl- 17β- hydroxide -4, 9, 11- triene -3-ketone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320041 | Single preparation containing mestanolone or methenolone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320042 | Single preparation containing methandriol or methyltestosterone or mibloerone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale single preparation containing nandrolone or | 0% | 13 | - |
| 3004320043 | Single preparation containing norbolethone or norclostebol, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320044 | Single preparation containing 19-norandrostenediol or 19-norandrostenedione, and their derivatives and structural analogues, in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320045 | Single preparation containing norandrosterone or norethandrolone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320046 | Single preparation containing19- noretiocholanolone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320047 | Single preparation containing oxabolone or oxandrolone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320048 | Single preparation containing oxymesterone or oxymetholone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320049 | Single preparation containing 17β-hydroxy-5α-androstane [3, 2-c] pyrazole, and their derivatives and structuralanalogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320051 | Single preparation containing quinbolone or tibolone or trenbolone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320052 | Single preparation containing stanozolol or stenbolone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320053 | Single preparation containing 1-testosterone or testosterone, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320054 | Single preparation containing tetrahydrogestrinone or zeranol, and their derivatives and structural analogues, put up in measured doses, packings for retail sale | 0% | 13 | - |
| 3004320060 | For veterinary use, the dosage of the preparation has been increased. | 5% | 15.00 | 17.00 |
| 3004320061 | Formulated dosage of veterinary preparations (including commodities in the Management Catalogue of imported veterinary drugs; including retail packaging) | 0% | 13 | - |
| 3004320071 | Single preparation containing 5- androstene diol (3 β, 17 β), and their derivatives and structuralanalogues, not containing antibiotics, put up in measured doses | 0% | 13 | - |
| 3004320072 | Single preparation containing 4-androstenedione, and their derivatives and structuralanalogues, not containing antibiotics, put up in measured doses | 0% | 13 | - |
| 3004320073 | Single-sided preparation containing boric acid at dosage adjusted | 5% | 15.00 | 17.00 |
| 3004320074 | Single preparation containing 7α-hydroxytestosterone, and their derivatives and structuralanalogues, put up in measured doses | 0% | 13 | - |
| 3004320075 | Single preparation containing 7β-hydroxytestosterone, and their derivatives and structuralanalogues, not containing antibiotics, put up in measured doses | 0% | 13 | - |
| 3004320076 | Single preparation containing 7-hydroxytestosterone, and their derivatives and structuralanalogues, not containing antibiotics, put up in measured doses | 0% | 13 | - |
| 3004320077 | Single preparation containing etiocholanolone, and their derivatives and structuralanalogues, not containing antibiotics, put up in measured doses | 0% | 13 | - |
| 3004320078 | Single preparation containing 1,4-androstenedione(androsterone-1,4-diene-3,17-dione), and their derivatives and structuralanalogues, not containing antibiotics, put up in measured doses | 0% | 13 | - |
| 3004320090 | Medications that contain other corticosteroid hormones at prescribed doses | 5% | 15.00 | 17.00 |
| 3004320099 | Drugs containing corticosteroid hormone, and their derivatives and structural analogues, not containning antibiotics, put up in measured doses, packings for retail sale | 0% | 0 | 13 |
| 3004390011 | Single preparation containing clenbuterol, put up in measured doses, (including packings for retail sale) | 0% | 13 | - |
| 3004390022 | Recombinant human growth hormone injection (only including drugs that comply with rare disease drug value-added tax policies) (growth hormone releasing peptides (GHRPs), growth hormone releasing peptide-1, -2, -3, -4, -5, -6; Growth hormone (GH), growth h | 5% | 15.00 | 17.00 |
| 3004390025 | Other monotherapy formulations containing chorionic gonadotropin, luteinizing hormone, etc. (including growth hormone releasing peptides (GHRPs), pramerelin (growth hormone releasing peptide-2), CJC-1295 (CAS No. 863288-34-0), growth hormone releasing pep | 0% | 13 | - |
| 3004390026 | Single preparation peptide hormones (including retail packaging and have dosage or retail packaging Ai Rui Mo Ruilin, sea corticorelin ,Iraq Mo Ruilin,Mo Ruilin,Mo Ruilin,Gore Bernard on behalf of triptorelin,Ge Ruilin(brain gut peptide) and its preparati | 0% | 13 | - |
| 3004390027 | Other monotherapy formulations containing leuprorelin that have been dosed (excluding drugs that comply with anti-cancer and rare disease drug value-added tax policies) | 0% | 13 | - |
| 3004390028 | Single preparation containing androsterone, in measured doses | 0% | 13 | - |
| 3004390029 | Other protein assimilation preparations and peptide hormones listed in the Doping Catalogue (excluding drugs that comply with the value-added tax policy for anti-cancer and rare disease drugs) | 0% | 13 | - |